FDA Orange Book
Generic for Uceris
Uceris contains budesonide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Uceris is budesonide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Uceris and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Uceris products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| aerosol, foam, rectal | 2MG/ACTUATION | Marketed (Rx) | AB | 1 | AB |
| tablet, extended release, oral | 9MG | Marketed (Rx) | AB | 2 | AB |
NDA 205613, 203634, held by SALIX PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic budesonide
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| ACTAVIS LABORATORIES FL INC | 205457 | AB (A-rated, therapeutically equivalent) | July 3, 2018 | 9MG |
| MYLAN PHARMACEUTICALS INC | 208851 | AB (A-rated, therapeutically equivalent) | September 17, 2020 | 9MG |
| PADAGIS ISRAEL PHARMACEUTICALS LTD | 215328 | AB (A-rated, therapeutically equivalent) | April 12, 2023 | 2MG/ACTUATION |
Uceris patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9192581 | September 7, 2031 | Drug product | U-1325 | 203634 |
| 8895064 | September 7, 2031 | Drug product | None | 203634 |
| 10660858 | September 7, 2031 | Drug product | None | 203634 |
| 10307375 | September 7, 2031 | Drug product | None | 203634 |
| 9132093 | September 7, 2031 | Drug product | None | 203634 |
Uceris NDC codes
Questions
Is there a generic for Uceris?
Yes. The generic name for Uceris is budesonide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Uceris?
The active ingredient in Uceris is budesonide, per the FDA Orange Book.
When does the Uceris patent expire?
The last patent listed for Uceris in the Orange Book expires September 7, 2031. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Uceris and Budesonide
- What is Budesonide used for?FDA label uses
- Is Budesonide a controlled substance?Federal schedule
- Generic for Entocort ECFDA Orange Book
- Generic for TarpeyoFDA Orange Book
- Generic for Pulmicort FlexhalerFDA Orange Book
- Generic for Pulmicort RespulesFDA Orange Book
- Generic for EohiliaFDA Orange Book
- Corticosteroids listFDA drug class
- NDC 65649-651Uceris NDC record
- NDC 68012-309Uceris NDC record